Simi Valley, CA, United States of America

Vyacheslav Brover

This inventor holds 52 USPTO granted patents and 12 published patent applications, primarily in Plant Biotechnology (CPC class C12N). Top assignee: Ceres, Inc.. Active years: 2008-2025.

USPTO Granted Patents = 52 

% Patents Active = 48.1

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 246(Granted Patents)

Forward Citations (Not Self Cited) = 178(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • North Potomac, MD (US) (2014 - 2018)
  • Rockville, MD (US) (2022 - 2023)
  • Simi Valley, CA (US) (2008 - 2024)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Areas of Expertise:
Polynucleotide Sequences
Nucleotide Sequences
Polypeptides
Modified Phenotype
Plant Growth
Regulatory Sequence
Trehalose-6P Phosphatase
Zinc Finger Proteins
Transcription Factors
Cytochrome P450
Invertase Proteins
Biomass Modulation
52 patents (USPTO):Explore Patents

Title: Vyacheslav Brover - Pioneering Inventor from Simi Valley

Introduction: Vyacheslav Brover is a distinguished inventor based in Simi Valley, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Brover's recent patents include innovative solutions in renewable energy systems, advanced robotics, and artificial intelligence applications.

Career Highlights: With a career spanning over two decades, Brover has established himself as a leading figure in the tech industry, with a strong focus on sustainability and cutting-edge technologies.

Collaborations: Throughout his career, Brover has collaborated with top research institutions, leading companies, and renowned universities to bring his inventions to life and make a lasting impact on the world.

Conclusion: Vyacheslav Brover's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a visionary inventor shaping the future of various industries.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…